SS-31 is a mitochondria-targeted tetrapeptide. Its mechanism of action primarily involves the mitigation of mitochondrial dysfunction, a common factor in many degenerative diseases and age-related conditions.
The peptide selectively targets cardiolipin, an essential phospholipid in the inner mitochondrial membrane, preserving its function and structure. By preventing the formation of reactive oxygen species (ROS), it mitigates oxidative stress and cellular damage. Research suggests SS-31’s diverse benefits extend across heart disease, neurodegenerative disorders, kidney disease, and aging, improving mitochondrial function.
Showing all 3 results
[1] https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC4921212/
[2] https://pubmed.ncbi.nlm.nih.gov/34302976/
[3] https://pubmed.ncbi.nlm.nih.gov/29589186/
[4] https://www.auajournals.org/ doi/full/10.1016/j.juro.2017.02.3115
[5] https://pubmed.ncbi.nlm.nih.gov/26719366/
[6] https://pubmed.ncbi.nlm.nih.gov/17151329/
[7] https://pubmed.ncbi.nlm.nih.gov/30381054/
[8] https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC5847870/
[9] https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC2584902/
ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.
DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Direct Peptides website: https://cyprus.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.
401 N. Mills Ave, Ste B, Orlando, FL 32803, United States